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Although the basic structure of the axoneme has been
highly conserved throughout evolution, the varied func-
tions of specialized axonemes require differences in
structure and regulation. Cilia lining the respiratory
tract propel mucus along airway surfaces, providing a
critical function to the defense mechanisms of the pul-
monary system, yet little is known of their molecular
structure. We have identified and cloned a dynein heavy
chain that is a component of the inner dynein arm. Bron-
chial epithelial cells were obtained from normal donors
and from a patient with primary ciliary dyskinesia
(PCD) whose cilia demonstrated an absence of inner
dynein arms by electron microscopy. Cilia from normal
and PCD cells were compared by gel electrophoresis,
and mass spectrometry was used to identify DNAH7 as a
protein absent in PCD cilia. The full-length DNAH7
cDNA was cloned and shares 68% similarity with an
inner arm dynein heavy chain from Drosophila. DNAH7
was induced during ciliated cell differentiation, and im-
munohistochemistry demonstrated the presence of
DNAH7 in normal cilia. In cilia from PCD cells, DNAH7
was undetectable, whereas intracellular DNAH7 was
clearly present. These studies identify DNAH7 as an in-
ner arm component of human cilia that is synthesized
but not assembled in a case of PCD.
The basic structure of the axoneme consisting of nine outer
microtubule doublets surrounding a central pair (9  2 ar-
rangement) is one of the most highly conserved structures in all
of cell biology (1, 2). The 9  2 arrangement is found in many
diverse organisms ranging from the flagella of Chlamydomonas
and the gill cilia of freshwater mussels to the sperm flagella of
sea urchins and respiratory tract cilia of humans. Despite the
structural similarity, each of these axonemes is specialized for
a particular function. Thus, the waveform of a sperm flagellum
(3), which functions to propel the sperm forward, is very differ-
ent from the coordinated beating of respiratory tract cilia,
which function to transport mucus over airway surfaces (4).
Moreover, the regulation of the activity of each specialized
axoneme is also likely to be unique. For example, increases in
Ca2 have been shown to stimulate ciliary beating of tracheal
epithelial cells (5), whereas Paramecium cilia respond to in-
creased Ca2 by reversing the direction of beating (6). These
functional differences are a reflection of unique modifications of
the structure and composition of each specialized axoneme. For
example, Chlamydomonas flagella have three outer arm dy-
nein heavy chains (DHCs)1 (7), whereas outer arms from mam-
malian respiratory cilia have been reported to contain only two
DHCs (8). Therefore, it is clear that although the basic struc-
ture and components of cilia and flagella are conserved, spe-
cialization of function has resulted in important variations of
structure and regulation among the different motile axonemes.
The Chlamydomonas flagellum represents the most thor-
oughly characterized axonemal structure. Through the use of
readily obtained mutants and computer-assisted image analy-
sis of electron micrographs, the positions and functions of many
of the proteins that make up the inner and outer dynein arms,
which provide the force for axonemal motility, have been iden-
tified in this species. As noted above, the outer dynein arms of
Chlamydomonas contain three DHCs known as , , and  (7).
The arrangement and composition of DHCs in the inner arms
are more complex with at least eight different DHCs organized
into seven distinct inner arm complexes (9). In contrast, our
understanding of mammalian axonemes, including human res-
piratory tract cilia, is limited. This is partly because of the
difficulties involved in obtaining sufficient material for bio-
chemical characterization but also because, unlike Chlamydo-
monas, the development of mutants (i.e. murine knock-out
models) is time- and labor-intensive. However, there is a nat-
urally occurring disease in which individuals display an inher-
ited defect in ciliary function known as primary ciliary dyski-
nesia (PCD) (10, 11). Cilia from PCD patients demonstrate an
abnormal pattern of ciliary beating and in some cases are
completely immotile. In most cases of PCD, the defects in
ciliary function are correlated with abnormal ciliary structure
with the absence of inner and/or outer dynein arms being the
most frequently reported defect. Thus, cilia from these individ-
uals are analogous to mutant flagella from Chlamydomonas,
and studies of these defective cilia will probably yield new
information about the structure of mammalian axonemes.
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To further our understanding of the structure and regulation
of human respiratory tract cilia, we have begun a detailed
characterization of the components of this complex organelle.
By culturing human bronchial epithelial (HBE) cells under
conditions that support ciliated cell differentiation, we have
obtained sufficient quantities of human ciliary axonemes for
biochemical and molecular analysis. As an approach to identify
specific components of the inner dynein arm, ciliary axonemes
from normal cells were compared with ciliary axonemes from
PCD cells lacking inner dynein arms. Proteins absent in the
PCD cilia were identified by mass spectrometry of the corre-
sponding protein from control cilia. This approach identified
human DNAH7 as a likely component of the axonemal inner
arm. To further characterize this DHC, the partial sequence
data obtained by mass spectrometry were used to clone a full-
length cDNA. The expression of DNAH7 during ciliogenesis
was examined both by Northern blotting and by using specific
antibodies developed against a recombinant fragment of the
protein. Finally, the expression of DNAH7 was examined in
HBE cells from the PCD patient.
EXPERIMENTAL PROCEDURES
Cell Culture—HBE cells were obtained from excess surgical tissue
under protocols approved by the University of North Carolina Institu-
tional Review Board. HBE cells were obtained from normal subjects
(transplant donors), a patient with established PCD who required a
lung transplant, and as disease controls, cystic fibrosis patients. No
differences were observed between cilia from the normal and cystic
fibrosis cells. Passage 1 or passage 2 HBE cells were grown at an
air-liquid interface using previously described procedures (12, 13) with
only minor modifications. 5–10  105 passage 1 or passage 2 HBE cells
were plated on 30-mm-diameter Millicell-CM culture inserts (Millipore
Corp., Bedford, MA) previously coated with rat tail collagen (BD
PharMingen). After reaching confluence, medium was removed from
the apical surface, and cultures were fed from only the basal surface for
the remainder of the experiment. The medium was replaced every 2–3
days, and cilia were isolated from well differentiated cultures after 4–6
weeks.
Isolation of Cilia—Cilia were isolated essentially as described previ-
ously (14, 15). Heavily ciliated cultures were washed with phosphate-
buffered saline (PBS) to remove mucus and cell debris. Deciliation
buffer (14) was added to the surface, and the culture was rocked gently
for 1 min. The supernatant was collected, and the procedure was re-
peated. The two washings were pooled and after pelleting debris at
1000  g, the ciliary axonemes were collected by centrifugation at
16,000  g and frozen at 80 °C. Protein concentrations were estimated
using the BCA reagent (Pierce).
Gel Electrophoresis—For analysis of high molecular weight ciliary
proteins, samples were electrophoresed on 4% Tris-glycine-SDS gels
(Novex, San Diego, CA) according to the manufacturer’s instructions.
To facilitate analysis by mass spectrometry, proteins were visualized by
staining with colloidal blue (Pro-Blue, Owl Separation Systems,
Woburn, MA) according to the manufacturer with the omission of the
first fixation step.
Mass Spectrometry Analysis—In-gel digestion with trypsin, liquid
chromatography-tandem mass spectrometry (LC/MS/MS), and search-
ing of data bases were all performed using standard techniques essen-
tially as described previously (16).
Cloning, Sequencing, and Analysis of DNAH7—Mass spectrometry of
the high molecular weight protein identified a partial cDNA sequence
(GenBankTM accession number Z83801) encompassing the P1-loop of a
DHC. The sequence of DNAH7 that lies 5 to the P1-loop was obtained
by sequence walking employing successive steps of PCR with vector
primers and DNAH7-specific primers obtained from verified sequences
from the previous step. An oligo(dT) and random-primed cDNA library
generated from heavily ciliated HBE cell RNA prepared by Stratagene
in ZAP was used as template. The sequence of DNAH7 that lies 3 to
the P1-loop was obtained by amplification of the sequence between the
P1-loop region and another partial cDNA sequence identified by mass
spectrometry, KIAA0944 (GenBankTM accession number AB023161). In
general, PCR was performed for 40 cycles (4 min at 94 °C initially
followed by 40 cycles of denaturation at 94 °C for 30 s, annealing at
60 °C for 30 s, and extension at 68 °C for 5 min) using a GeneAmp PCR
System 9700 (PerkinElmer Life Sciences). Reaction conditions were as
follows: 50 l of total volume containing 2 l of cDNA library superna-
tant, 25 pmol of each primer, 0.75 l of enzyme mix (Expand Long
Template PCR System, Roche Molecular Biochemicals) in the buffer
system provided by the manufacturer. The resulting PCR products were
cloned into pCR2.1TOPO (Invitrogen) and sequenced in the University
of North Carolina at Chapel Hill Automated DNA Sequencing Facility.
Reverse transcription (RT)-PCR was used to verify the sequence
obtained from the library and to search for mutations in the PCD
patient. Primer pairs located throughout the sequence were used that
yielded 24 overlapping sequences of 700–800 bp. Total RNA was iso-
lated from well differentiated cultures of HBE cells using Tri-Reagent
(Molecular Research Center, Inc., Cincinnati, Ohio). First strand cDNA
was prepared using 3 g of total RNA and 250 ng of random primers
with SuperScript II RNaseH reverse transcriptase (Invitrogen) ac-
cording to manufacturer’s instructions. 1 l of the first strand reaction
was used in a 50-l PCR mixture containing 10 pmol of each primer, 2.5
units of AmpliTaq DNA polymerase (PerkinElmer Life Sciences) in
manufacturer’s buffer with 2 mM MgCl2. Reaction conditions were as
follows: initial denaturation at 94 °C for 3 min, 40 cycles of 94 °C for
30 s, 57 °C for 30 s, and 72 °C for 1 min with a final 10-min extension
at 72 °C. RT-PCR products were gel-purified using QIAquickTM gel
extraction kits (Qiagen, Valencia, CA). Products were directly se-
quenced in the University of North Carolina at Chapel Hill Sequencing
Facility using DNAH7-specific sequencing primers.
To verify identified sequence variations on genomic DNA, genomic
sequence from the data base (GenBankTM accession numbers
AC068528, AC068919, and AC013274) was used to design primers on
either side of the variation, usually one primer in the exon and one
primer in the intronic region surrounding the exon. These primers were
used to amplify the region of interest from genomic DNA (50 ng). PCR
conditions and sequencing were as described above for RT-PCR.
Sequence assembly and analyses were performed using Vector NTI
suite 6 (InforMax), GCG (Genetics Computer Group), and BLAST
(NCBI) programs.
Antibody Production and Characterization—For antibody produc-
tion, a 0.8-kb BglII/EcoRI cDNA fragment of DNAH7 consisting of
amino acids 1531–1780 of our established sequence was cloned into the
bacterial expression vector pET-28a (Novagen, Madison, WI) to gener-
ate plasmid pET-H7. This construct was used to produce a DNAH7
peptide that was designated H7. In addition, a peptide from a similar
region of DNAH9 (GenBankTM accession number AF257737) consisting
of amino acids 2057–2346 was obtained by PCR of the differentiated
airway cell library using primers 5-ATCAAGTCCGTGCTGGTGG-3
and 5-CAAGATCTGAACCATGCTCTGCTCTG-3, which contains a
BglII site. The product was cloned into the pET-28a vector using BglII
and BamHI (the BamHI site was in the DNAH9 cDNA sequence) to
produce plasmid pET-H9. This plasmid produced a peptide that was
designated H9.
For antibody production, the H7 peptide was expressed and purified
from Escherichia coli strain BL21(DE3) (Novagen) using a HisTrap
purification kit (Amersham Biosciences) according to the manufactur-
er’s instructions. The purified protein was further fractionated by poly-
acrylamide gel electrophoresis, and the band containing H7 peptide was
excised and submitted to Aves Laboratories (Tigard, OR) for immuni-
zation to obtain chicken anti-DNAH7 antibody. The chicken IgY from
the eggs of the immunized chickens was purified by the manufacturer.
For testing the specificity of the antibodies produced, [35S]methi-
onine-labeled H7 and H9 proteins were generated using TNT T7-cou-
pled rabbit reticulocyte lysate system (Promega) in the presence of
[35S]methionine (ICN Biomedicals, Costa Mesa, CA) according to the
manufacturer’s protocol using plasmids pET-H7 and pET-H9 as tem-
plates. Immunoprecipitation was conducted by mixing 1 l of in vitro
translated [35S]methionine-labeled proteins with 1 l of anti-DNAH7
chicken IgY. The mixture was then incubated with 25 l of immobilized
anti-chicken IgY (Promega) in 500 l of PBS containing 1% Empigen
BB detergent, 1 mM EDTA, and 0.1 mM dithiothreitol at 4 °C for 1 h.
Unbound proteins were removed by several washes of the beads with
the binding buffer. Bound proteins were eluted with SDS-PAGE loading
buffer (50 mM Tris, pH,6.8, 2% SDS, 0.1 M dithiothreitol, 10% glycerol,
0.1% bromphenol blue) separated by gel electrophoresis and visualized
by fluorography.
Western Blotting—Cultured cells were washed with cold PBS and
scraped into SDS lysis buffer (100 mM Tris, pH 6.8, 4% SDS, 20%
glycerol). Samples were then boiled for 5 min and passed through a
25-G needle 10 times to shear the genomic DNA. The lysate was clar-
ified by centrifugation at 13,000 rpm for 5 min at 4 °C, and protein
concentrations were determined using the BCA kit. One-tenth volume
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of 1 M dithiothreitol and 1% bromphenol blue were added before gel
electrophoresis. The total cell lysates (50 g) or aliquots of purified cilia
were separated on precast gels (Novex, San Diego, CA) according to the
manufacturer. Gels were transferred to polyvinylidene difluoride mem-
branes (Amersham Biosciences) in NuPAGE transfer buffer at 30 volts
for 2 h using the Novex Xcell blotting apparatus. Polyvinylidene diflu-
oride membranes were blocked with BlockHen (Aves Laboratories) di-
luted 1:5 in PBST (0.58 M Na2HPO4, 0.017 M NaH2PO4, 0.68 M NaCl,
0.05% Tween 20) or with 5% milk in PBST followed by the incubation
with the chicken anti-DNAH7 IgY (1:10,000 dilution) or anti--tubulin
IV (1:4000 dilution, monoclonal, Biogenetex, Seabrook, TX) for 1 h.
-Tubulin IV is known to be localized in cilia (17) and was used as a
control for axonemal protein loading. Membranes were then washed
with PBST plus 1% milk and incubated with a 1:20,000 dilution of
horseradish peroxidase-conjugated secondary antibodies (goat anti-
chicken IgY from Aves Laboratories or rabbit anti-mouse IgG from
Jackson ImmunoResearch Laboratories, West Grove, PA). Immunore-
activity was detected using ECL-plus (Amersham Biosciences) accord-
ing to the manufacturer’s instructions.
Immunohistochemistry—For immunostaining, ciliated cultures of
HBE cells were washed with PBS, fixed with 4% paraformaldehyde for
30 min, and embedded in paraffin. The sections were deparaffinized
twice in xylene and rehydrated in an ethanol series. Slides were then
immersed in methanol containing 0.6% hydrogen peroxide for 15 min to
inactivate endogenous peroxidase activities. Slides were incubated for
1 h in blocking buffer (5% goat or rabbit serum, 1% gelatin, 1% bovine
serum albumin in PBS plus 0.05% Tween 20) and then for 1 h with the
anti-DNAH7 (1:250 dilution in blocking buffer) or anti--tubulin IV
(diluted 1:500) antibodies. Preimmune IgY from the same chicken that
generated the anti-DNAH7 antibody was used as a control for anti-
DNAH7 antibody at a 4-fold higher concentration. The sections were
then washed with PBST followed by incubation with horseradish per-
oxidase-conjugated secondary antibody (1:500) for 1 h. The signal was
detected with SIGMAFAST DAB (Sigma) for 15 min. The sections were
lightly counterstained with methyl green, dehydrated in ethanol, and
coverslipped with permount.
Northern Analysis—15 g of total RNA isolated as described above
was separated in a 1% agarose-formaldehyde gel according to North-
ernMaxTM protocols (Ambion, Austin, TX). RNA was transferred to
Hybond-XL membrane (Amersham Biosciences) by capillary blotting
according to the manufacturer’s instructions and cross-linked using a
Stratalinker (Stratagene). A gel-purified PCR fragment containing nu-
cleotides 51–812 of DNAH7 cDNA was used as a probe for detecting
DNAH7 expression. A DNA fragment containing nucleotides 1–718 of
the human intermediate chain dynein cDNA (IC78, GenBankTM acces-
sion number NM_012144), another protein known to be associated with
cilia (18), was obtained by PCR from the differentiated airway cell
library. This fragment was used as a probe to detect IC78 message.
Probes were labeled with 32P using Megaprime DNA-labeling system
(Amersham Biosciences) and purified on MicroSpinTM G-50 columns
(Amersham Biosciences). Hybridizations were performed in Rapid-hyb
buffer (Amersham Biosciences) at 65 °C, and blots were washed accord-
ing to manufacturer’s instructions before being exposed to film at
70 °C with intensifying screens.
Image Analysis—Light microscope images were captured with a
Hamamatsu C5810 color 3CCD camera (Hamamatsu Photonic Sys-
tems, Bridgewater, NJ) and processed in Adobe Photoshop 6.0 (Adobe
Systems, Inc., San Jose, CA). Electron micrographs and blots were
scanned with a Umax powerlook III flatbed scanner (Umax Technolo-
gies, Inc., Fremont, CA) and also processed in Adobe Photoshop.
RESULTS
Identification of Inner Arm Axonemal Dynein Heavy
Chains—Normal HBE cells were cultured at an air-liquid in-
terface under conditions that favor mucociliary differentiation.
Under these conditions, HBE cells differentiate to produce a
heavily ciliated epithelium that resembles native tracheobron-
chial epithelium (12, 13). Cilia in these cultures become coor-
dinated and are capable of actively transporting mucus (19).
Cilia were isolated from these well differentiated cultures by
using a non-ionic detergent in the presence of calcium (14, 15).
These preparations are highly enriched for cilia (Fig. 1, A and
B) and consist primarily of intact ciliary axonemes with the 9 
2 microtubules, inner and outer dynein arms, and radial spokes
clearly visible (Fig. 1C).
HBE cells were obtained from a PCD patient who underwent
a lung transplant operation for severe bronchiectasis. Light
microscopic examination of cilia obtained from a nasal scrape
demonstrated abnormal ciliary motion. Electron microscopy
revealed a number of ciliary abnormalities with the most con-
sistent defect being a deficiency of inner dynein arms. Thus,
although structures resembling outer dynein arms were ob-
served on a majority of axonemal doublets, the inner arm
structures were only rarely observed (Fig. 2, A–C). These PCD
cells when cultured at an air-liquid interface differentiated
normally to produce a mucociliary epithelium. These cultures
also reproduced the phenotypic defect present in PCD patients.
Whereas cilia of normal or non-PCD disease control (i.e. cystic
fibrosis) cells exhibited abundant ciliary activity, which fre-
quently was coordinated, the cilia in the PCD cultures ap-
peared straight and rigid and beat only infrequently. Electron
micrographs of cilia from cultured PCD cells also reproduced
the deficiency of inner dynein arms observed in the freshly
excised tissue.
To identify components of the inner dynein arm, cilia were
isolated from differentiated cultures of normal and disease
control (cystic fibrosis) HBE cells and compared with cilia
isolated from differentiated cultures of PCD cells. Proteins that
are components of the inner dynein arm, including the inner
arm DHCs, would be expected to be absent or greatly reduced
in the axonemes from the PCD cells. Because DHCs are too
large to resolve by two-dimensional gel electrophoresis (molec-
ular mass of 500 kDa), we examined the DHC composition of
these samples by SDS-PAGE on low percentage gels. Under
these conditions, four bands were clearly resolved from the
normal axonemes in the high molecular weight region of the gel
where DHCs would be expected to migrate (Fig. 3A). In most
samples, the two upper bands appeared more intense than the
lower two bands and are likely to contain outer arm DHCs (14,
15). In contrast, axonemes isolated from the PCD cells showed
a distinct absence of the lowest of the four high molecular
weight protein bands. To verify that this was a specific reduc-
tion in the protein(s) present and not a sample preparation or
loading artifact, different quantities of axonemal proteins iso-
lated from normal and cystic fibrosis cultures were compared
FIG. 1. Isolated cilia from cultures of HBE cells. Cilia were
isolated from well differentiated cultures of HBE cells and examined by
light (A) and electron (B and C) microscopy. The preparation consists of
mostly intact ciliary axonemes with inner and outer dynein arms pres-
ent. A, Richardson’s stain, original magnification at 40. B and C, fixed
in 2% paraformaldehyde/2% glutaraldehyde with 1% tannic acid. Scale
bars  1.1 m (B); 50 nm (C).
FIG. 2. PCD cilia are deficient in inner dynein arms. Cilia ob-
tained from a nasal scrape of a control (A) and the PCD patient (B and
C) were examined by electron microscopy. Although both inner and
outer dynein arms are clearly visible in the control, cilia from the PCD
patient demonstrated an almost complete absence of inner arm struc-
tures. Scale bar  50 nm.
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with axonemes isolated from PCD cultures as noted above and
analyzed by densitometry (Fig. 3B). This experiment shows
that even when less protein was loaded from the control sam-
ples, all four protein bands were clearly detected. This result
demonstrates that in the PCD cilia, a protein or proteins pres-
ent in this lowest band are specifically reduced or absent.
Because this protein band is likely to represent inner arm
components, we sought to identify the protein(s) present in this
band. Isolated axonemes from control cultures were separated
by SDS-PAGE as described above, and the lowest of the four
high molecular weight protein bands was excised. To obtain
sufficient sample for analysis by mass spectrometry, 40 gel
slices from several different cultures were pooled. The protein
was digested with trypsin, and the purified peptides were an-
alyzed by capillary LC/MS/MS. High quality amino acid se-
quence was obtained on 30 peptides. An initial search of the
data bases using Mascot identified seven peptides that
matched DHC sequences, including several with an identity to
known human DHCs (Table I). These peptides matched se-
quences located near the conserved catalytic region of DHCs
including two human dyneins identified as HDHC2 (Gen-
BankTM accession number Z83801 (20)) and DHC3 (Gen-
BankTM accession number U53532 (21)). These results were
not unexpected, because the catalytic region around the first
nucleotide-binding site (P-loop region) of the DHCs is highly
conserved and is the region most represented in the data base.
Both of these sequences are probably derived from inner arm
axonemal DHCs. Because there are no other human full-length
inner arm sequences available to date, the other peptides are
most likely derived from sequences outside the conserved P-
loop region and may represent additional inner arm DHCs.
One sequence (Table I, row number 1) was uniquely specific for
a human DHC previously identified as HDHC2 and is the
subject of this report.
Cloning and Characterization of a Full-length cDNA for Ax-
onemal Dynein DNAH7—To further characterize this human
DHC and investigate its possible role in PCD, the full-length
sequence was obtained by a combination of techniques. An-
chored PCR was used to walk in the 5 direction from the P-loop
region of HDHC2 using a library constructed from heavily
ciliated cultures of human airway cells (see “Experimental
Procedures” for details). To obtain the 3 end of the cDNA, we
again took advantage of the mass spectrometry data. During
the course of this work, the peptide sequences obtained by
LC/MS/MS were used to search the data bases for newly de-
posited sequences. One of these searches resulted in the iden-
tification of a partial cDNA isolated from human brain desig-
nated KIAA0944 (GenBankTM accession AB023161 (22)),
which contained sequences coding for several peptides from the
isolated protein band. This partial cDNA is homologous to an
inner arm DHC from sea urchin and is likely to represent one
of the inner arm DHCs absent from the cilia of the PCD patient.
To determine whether this cDNA was related to either of the
dyneins previously identified by mass spectrometry, specific
primers were designed to the 3 ends of the HDHC2 and DHC3
sequences and to the 5 end of the KIAA0944 sequence. PCR
FIG. 3. Analysis of axonemal pro-
teins by gel electrophoresis. A, differ-
ent amounts of isolated axonemes from
normal, cystic fibrosis, or PCD cells were
electrophoresed on an acrylamide gel and
stained with colloidal Coomassie Blue. B,
densitometric tracings of the gel shown in
A. The results demonstrate that the low-
est of the four high molecular weight pro-
tein bands is undetectable in axonemes
from the PCD patient. In contrast, four
bands are clearly present in the control
samples, even when less total protein is
loaded.
TABLE I
Peptide matches obtained from LC-MS/MS of the isolated high molecular weight protein
Sequence m/z GenBank™ accession number Description
1 GINAGADILMFEGTELK 889.8 Z83801 Human dynein heavy chain
2 YAYEYLGNSPR 666.8 U53532 Human dynein heavy chain
3 IGDST(L/I)EYAPDFR 742.3 P23098 Sea urchin dynein
4 MVVFVDDVNMPAR 754.7 U03970 Sea urchin dynein
5 ELQNQLNEIVELVR 848.9 U53532 Human dynein heavy chain
6 ...NDGFVEADDLR 870.7 U03978 Sea urchin dynein
7 ...SDDSDFEWKSQR 913.3 U53532 Human dynein heavy chain
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amplification of aliquots of the cDNA library was performed
with different combinations of these primers. Only the HDHC2
primer combined with the KIAA0944 primer yielded a product
(Fig. 4A, fragment D1). The cloning and sequencing of this
3.8-kbp fragment demonstrated the expected identity to
HDHC2 and KIAA0944 at both ends. Additional primers were
designed to the newly obtained internal sequence of this frag-
ment and used to amplify additional fragments from the cDNA
library in both the 3 and 5 directions. The 3 products ob-
tained were identical to KIAA0944, confirming the sequence of
this region. However, clones obtained in the 5 direction
showed identity to another partial dynein sequence, DNAH7
(GenBankTM accession AJ132084 (23)), while showing four nu-
cleotide differences with HDHC2. These differences resulted in
two amino acid changes between DNAH7 and HDHC2 at posi-
tions 1353 (Asn  Asp) and 1355 (Ser  Pro) of the completed
sequence (see below). No other DHC sequence containing the
Asp and Pro residues predicted by the DHC2 sequence was
found in a search of the data bases. Because the original se-
quence of HDHC2 was obtained by PCR amplification using
degenerate P-loop primers, it is not clear whether the sequence
of HDHC2 represents another gene with nearly identical se-
quence to DNAH7 or whether the original sequence of HDHC2
was the result of a polymorphism. However, because the se-
quence we obtained was identical to the sequence of DNAH7,
we will refer to the sequence obtained here as DNAH7. The
entire 5 sequence of DNAH7 was obtained from the cDNA
library by several rounds of PCR walking.
FIG. 4. A, schematic of the PCR-based cloning strategy. The assembled cDNA of DNAH7 is shown at the top with the location of the P-loops
(ATP-binding sites) indicated. The fragment labeled D1 was derived by PCR from two sequences present in GenBankTM containing peptides that
were detected by MS analysis, hdhc2 (accession number Z83801) and KIAA0944 (accession number AB023161) (gray boxes). This fragment
completed the 3 end of the sequence. The 5 end of the gene was obtained by PCR walking from the hdhc2 sequence (walks indicated by arrows).
The first PCR walk in the 5 direction gave a sequence identical to another data base entry, DNAH7 (accession number HSA132084), indicated as
the black box. This sequence homology solidified the designation of the sequence as DNAH7. B, alignment of deduced amino acid sequence of
DNAH7 (H7) (GenBankTM accession number AF327442) with that of it closest known homologue, Drosophila melanogaster Dhc36C (36C)
(GenBankTM accession number AAF53626). Amino acids identical in both species are shown with a black background, whereas similar residues
are shaded. Gaps that were introduced to optimize the alignment are denoted by dashes. The asterisks indicate the four conserved P-loop regions.
Additionally, two putative ATP-binding sites are underlined. The regions showing the highest probability of forming helical-coiled coils are
indicated with an “X” underneath. The fragment of the protein expressed in bacteria and used for antibody generation is indicated by the dashed
overline. C, phylogenetic tree showing the relationship of DNAH7 with other full-length DHCs. A representative set of full-length, cytoplasmic,
inner, and outer arm DHCs were aligned to DNAH7 (Hu-DNAH7) with Align-X of Vector NTI suite using default parameters. DNAH7 maps to the
axonemal inner arm family. The percentage of similarity of DNAH7 to each DHC in a pairwise comparison is indicated. The GenBankTM accession
numbers of the dyneins are as follows: Chlamydomonas reinhardtii inner dynein arm 1- dynein heavy chain-IA (ChlamyDhc1), accession number
CAB56598; C. reinhardtii inner dynein arm 1- dynein heavy chain-IA (ChlamyDhc1), accession number CAB99316; D. melanogaster dynein
heavy chain dhc36c (DMDhc36c), accession number AAF53626; human outer dynein arm heavy chain DNAH9 (DNAH9), accession number
CAB94756; mouse outer dynein arm heavy chain DhC11 (left-right dynein) (MusDhc11-lrd), accession number NP_034190; mouse cytoplasmic
dynein heavy chain (MusDhc), accession number AAF91078; Rat cytoplasmic dynein heavy chain 1 (RatDhc1), accession number NP_062099.
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Because of the highly conserved nature of DHCs, additional
experiments were performed to verify that the completed se-
quence was derived from a single DHC. First, RT-PCR was
carried out directly on RNA isolated from well differentiated
cultures of human airway cells. Over 20 individual overlapping
products were generated and sequenced (see Fig. 4A and “Ex-
perimental Procedures” for details). These results verified that
the clones obtained from the cDNA library were part of a single
message. Second, the entire coding region of DNAH7 was am-
plified in two large overlapping fragments. Finally, nucleotides
3707–11530 of DNAH7 were found to align to a completely
assembled genomic clone (GenBankTM accession number
AC068919), further supporting the integrity of the sequence.
To further confirm the presence of DNAH7 in the isolated
protein band, the full-length sequence was searched with the
original peptide sequences obtained by mass spectrometry.
This resulted in 38 peptides being matched to the predicted
coding sequence providing conclusive evidence that DNAH7
was present in the sample. These data also provide additional
evidence for the correctness of the deduced coding sequence.
The assembled DNAH7 sequence (GenBankTM accession
number AF327442) contains a single long open reading frame
encoding a protein of 4025 amino acids with a predicted molec-
ular mass of 461,190 Daltons (Fig. 4B). An in-frame stop codon
is present upstream of the putative open reading frame, sug-
gesting that the first AUG is the start codon. Of the full-length
dynein sequences available, DNAH7 was most similar to the
Drosophila gene product Dhc36C, sharing 54.6% identity and
67.9% similarity overall (Fig. 4B). An analysis of the predicted
amino acid sequence demonstrated that DNAH7 shares many
of the conserved features of dynein heavy chains (24). Four well
conserved P-loops are located in the central domain of the
molecule (Fig. 4B), and two additional degenerate ATP-binding
sites are found in the C-terminal region. Two coiled coil do-
mains, which may form the “stalk” of the dynein molecule, are
predicted downstream from the fourth P-loop.
A phylogenetic analysis of DNAH7 compared with represent-
ative examples of available full-length inner, outer, and cyto-
plasmic DHC sequences (Fig. 4C) revealed that DNAH7 is most
probably an inner arm DHC, because it is more closely related
to inner arm DHCs of Chlamydomonas than to an outer arm
DHC of human or cytoplasmic DHCs from rat and mouse.
DNAH7 Is Induced during Ciliogenesis of HBE Cells and Is
Incorporated into the Ciliary Axoneme—The expression of
DNAH7 mRNA was examined during ciliogenesis of normal
HBE cells in culture. Initially, these cultures consist of a mono-
layer of undifferentiated basal-like cells. With time, the cul-
tures become pseudo-stratified and differentiate into a muco-
ciliary epithelium very similar to an in vivo airway. DNAH7
expression was not detected at early time points (Fig. 5, days 4
and 7) but was clearly induced during the period when differ-
entiation occurs and ciliated cells develop (days 14–28). This
pattern of expression has been observed for other axonemal
proteins (15, 25) and supports the conclusion that DNAH7 is an
axonemal DHC.
Specific antibodies were generated to allow characterization
of the DNAH7 protein. A fragment of DNAH7 containing amino
acids 1531–1780 was expressed in bacteria. To reduce the pos-
sibility of cross-reactivity with other DHCs, the portion of
DNAH7 expressed was chosen not to contain the highly con-
served first P-loop region (see Fig. 4B). The recombinant frag-
ment was purified, injected into chickens, and IgY antibodies
were obtained. When used to probe Western blots of isolated
cilia, the antibody reacted with a single band of the expected
size (Fig. 6A), demonstrating that under these conditions the
antibody did not cross-react strongly with other DHCs. The
specificity of the purified antibodies was further examined by
expressing a similar portion of another human axonemal DHC,
DNAH9 (26), and testing the antibody against both peptide
fragments in an immunoprecipitation experiment. As shown in
FIG. 5. Northern analysis of DNAH7 expression during differen-
tiation. RNA was isolated from normal HBE cultures at the times indi-
cated and analyzed for DNAH7 expression. The filter was reprobed with
IC78, an intermediate dynein chain, as a control for axonemal gene
expression. The ethidium bromide staining of the 28 S rRNA (bottom
panel) demonstrates equivalent loading. DNAH7 and IC78 are not ex-
pressed in the undifferentiated cultures (days 4 and 7), whereas both
genes are expressed in differentiated ciliated cultures (days 14, 21, and
28).
FIG. 6. Analyses of DNAH7 protein expression. A, Western blot-
ting of axonemal proteins with an anti-DNAH7 antibody. The antibody
reacts specifically with the lowest of the four proteins bands (lane 2),
whereas preimmune antibody shows no reactivity (lane 3). Lane 1 was
silver-stained to visualize the protein pattern. B, the specificity of
anti-DNAH7 antibody was demonstrated by immunoprecipitation of
the H7 (lane 1) but not the H9 (lane 2) peptide produced by in vitro
translation. The labeled, translated H7 and H9 peptides before immu-
noprecipitation are shown in lanes 3 and 4, respectively. C, expression
of DNAH7 protein during differentiation. Total cell lysates were pre-
pared from cultures of normal HBE cells at the indicated time points.
DNAH7 was not detected early in culture but was induced during
ciliated cell differentiation. The lower panel shows a replicate gel
stained with Coomassie Blue to demonstrate equal loading.
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Fig. 6B, the anti-DNAH7 antibodies clearly immunoprecipi-
tated the labeled DNAH7 peptide while showing no cross-
reactivity with the DNAH9 peptide.
To examine the expression of DNAH7 during differentiation,
total cell lysates were prepared from normal HBE cell cultures
at different times and analyzed by Western blotting. As ex-
pected for an axonemal protein and in agreement with our
Northern analysis, no signal was detected at early time points
when the HBE cells were mostly undifferentiated (Fig. 6C,
days 2 and 5). DNAH7 protein was first detectable at day 9, and
the level of DNAH7 increased over the next 2–3 weeks during
the time when ciliated cell differentiation occurs.
To directly test for the presence of DNAH7 in intact cilia,
cultures of well differentiated HBE cells were examined by
immunohistochemistry with the anti-DNAH7 antibodies. The
cilia of these cultures stained intensely with the anti-DNAH7
IgY (Fig. 7) while the cultures stained with the control IgY at a
4-fold higher concentration showed only faint nonspecific stain-
ing. These results directly demonstrate that DNAH7 is present
in the cilia of HBE cells, again supporting the classification of
DNAH7 as an axonemal DHC.
DNAH7 Is Synthesized in PCD Cells but Is Not Assembled
into the Ciliary Axoneme—Because cilia from the PCD cells
showed a reduced level of the high molecular weight protein
band containing DNAH7 (Fig. 3), we also examined the expres-
sion of DNAH7 in cultures of PCD cells. Northern blot analysis
of well differentiated cultures of PCD demonstrated expression
of DNAH7 RNA (Fig. 8A), and Western blot analysis of total
cell lysates demonstrated that immunoreactive DNAH7 was
present in PCD cells (Fig. 8B). Although the level of DNAH7
RNA and protein appears reduced in the PCD cells, this most
probably reflects a difference in the extent of ciliated cell dif-
ferentiation (note that the level of IC78 also appears reduced in
the PCD cells). However, these results suggest that full-length
DNAH7 RNA was produced and the DNAH7 protein was being
translated correctly in the PCD cells. In contrast, Western
blotting of ciliary axonemes isolated from the cultured PCD
cells produced no signal, even though probing the sample with
an anti--tubulin IV antibody, a marker for ciliary axonemes,
revealed that ample material had been loaded on the gel (Fig.
8C). These results suggest that DNAH7 was being synthesized
by the PCD cells but either was not incorporated or was incor-
porated at low levels into the cilia.
To test this hypothesis further, well differentiated cultures of
PCD cells were examined by immunohistochemistry. As shown
in Fig. 9A, the anti-DNAH7 antibody produced no appreciable
staining of the PCD cilia, whereas the control antibody (anti-
-tubulin IV) stained the cilia strongly (Fig. 9B). Interestingly,
the anti-DNAH7 antibody stained the cytoplasmic region of the
PCD cells with equal or slightly greater intensity than the
control cells.
The data above would be consistent with a mutation in the
DNAH7 protein that prevented proper assembly of the cilia in
the PCD patient. To determine whether mutations in DNAH7
were responsible for the PCD phenotype in this patient, RNA
was isolated from well differentiated cultures of the PCD cells.
RT-PCR was then used to amplify overlapping fragments of the
entire DNAH7-coding region. These products were sequenced
directly and compared with the previously obtained sequence
from control cells to detect possible mutations and allelic vari-
ants. Any sequence variants were confirmed by sequencing
fragments amplified from genomic DNA and, if necessary, by
sequencing individual clones of PCR products. No deletions,
insertions, or premature stop codons were identified in the
sequence obtained from the PCD patient. Single nucleotide
variants were identified at seven locations in the coding region
of DNAH7 (Table II); however, only the C–T at position 1729
results in an amino acid substitution (Arg-Cys). To determine
whether any of these variants is associated with the occurrence
of PCD, additional unrelated control subjects were examined.
For each of the variants listed, non-PCD controls were identi-
fied that were homozygous for the variant allele, indicating
FIG. 7. Immunohistochemistry of DNAH7 in HBE cells. Paraffin
sections of well differentiated HBE cells were stained with either
the anti-DNAH7 antibody (A) or a 4-fold excess of preimmune IgY (B).
The anti-DNAH7 antibody reacted strongly with the cilia, whereas the
preimmune antibody showed no appreciable staining. Scale bar  10
m.
FIG. 8. DNAH7 expression in PCD cells. A, Northern blot analysis
of differentiated PCD cells demonstrates clear expression of DNAH7
RNA. The PCD sample was included on the gel shown in Fig. 5. B,
Western blot analysis of total cell lysates from well differentiated cul-
tures of control and PCD cells. The 293 cell lysate was included as a
negative non-ciliated control. DNAH7 protein is readily detected in
PCD cells. C, Western blot analysis of axonemal proteins isolated from
normal and PCD cells. Differing amounts of protein from the normal
axonemes were loaded as indicated, and Western blots were performed
with the chicken anti-DNAH7 or the mouse anti--tubulin IV (Anti-
tubIV). The amount of PCD cilia loaded was determined from a pre-
vious experiment to match the signal intensity obtained for -tubulin
IV at 2.5 g of normal cilia. These results indicate at least a 4-fold
decrease in DNAH7 in the cilia from the PCD patient.
Human Axonemal Dynein Heavy Chain DNAH7 17913
that these variants are most likely polymorphisms with no
functional consequence.
DISCUSSION
Human respiratory tract cilia are complex axonemal struc-
tures consisting of hundreds of different proteins, precisely
assembled and regulated to efficiently provide the force for
mucus clearance. Although the basic structure of nine outer
doublets and two central microtubules has been highly con-
served in motile axonemes, a specialization of function requires
that different axonemes have unique structures and be regu-
lated by different mechanisms. Thus, although significant pro-
gress has been made in understanding the detailed molecular
structure of Chlamydomonas flagella, it is obvious that to un-
derstand human cilia, a similar detailed analysis of human
material will need to be performed.
Previous investigations have used RT-PCR with degenerate
primers targeted to highly conserved regions of DHCs to am-
plify partial cDNAs of many human DHCs. For example,
Chapelin et al. (27) identified five axonemal DHCs expressed in
trachea, whereas Neesen et al. (20) identified seven axonemal
DHCs from testis. Based on homology to dyneins from other
species and phylogenetic analysis, these DHCs have been
grouped as inner or outer arm DHCs with no supporting bio-
chemical analysis. To date, a complete sequence has been as-
sembled for only one human axonemal DHC, DNAH9 (26), and
evidence provided by Reed et al. (15) support the classification
of this DHC as an outer arm component. However, no similar
studies have been reported for any human inner arm DHCs.
In this work, we have begun to characterize components of
the inner dynein arm of human respiratory tract cilia. By
comparing normal cilia with cilia from a PCD patient who was
diagnosed by analysis of electron micrographs with an absence
of inner dynein arms, we have identified and characterized the
first human full-length inner arm DHC. This approach is sim-
ilar to that used for studies of Chlamydomonas mutants that
lack specific axonemal structures. As a first step in our analy-
sis, the composition of DHCs in normal cilia was compared with
that in the PCD cilia. Gel electrophoresis demonstrated that
one of the four major DHC protein bands was clearly reduced in
the PCD cilia, and mass spectrometry identified DNAH7 as one
component of this band. Mass spectrometry also identified an-
other DHC, DHC3, which is also likely to be an inner arm
component. Several other peptides have not yet been identified,
suggesting that additional inner arm DHCs may migrate in
this region. The results suggest that by comparing cilia from
control and PCD patients using one- and two-dimensional gel
electrophoresis coupled with tandem mass spectrometry, addi-
tional protein components of human cilia can be identified and
their position in the axoneme localized.
To further characterize DNAH7, the entire cDNA was cloned
and sequenced from a HBE cell cDNA library. This finding
represents the first full-length sequence of a human inner arm
axonemal DHC and only the second full-length human axon-
emal DHC that has been assembled. DNAH7 shares all the
previously described features of axonemal DHCs, including
four conserved P-loop regions and two downstream coiled coil
domains. A comparison to other available full-length DHC se-
quences shows that DNAH7 is most homologous to a Drosoph-
ila inner arm DHC, Dhc36C, and is more homologous to other
inner arm DHCs from Chlamydomonas then to the outer arm
DHC from human, DNAH9. As shown by Northern and West-
ern analyses, DNAH7 was not expressed in undifferentiated
HBE cells but was strongly induced in differentiated ciliated
cells. Immunostaining of control HBE cells demonstrated that
DNAH7 was localized to the cilia, whereas cilia from the PCD
cells did not react with the anti-DNAH7 antibodies. Together
with the electron micrographs of the PCD cilia demonstrating
a lack of inner dynein arms, these data support the conclusion
that DNAH7 is a member of the inner arm family of DHCs.
The inability to correctly assemble DNAH7 onto the ciliary
axoneme is likely to be at least partially responsible for the
defective ciliary function and resultant disease in this PCD
patient. Therefore, we explored the possibility that mutations
in the DNAH7 gene were responsible for preventing the proper
assembly of the inner dynein arm. Northern analysis demon-
strated that DNAH7 mRNA transcripts were present at ap-
proximately normal levels, and RT-PCR confirmed that both
alleles were expressed, indicating that there were no large
deletions or truncations of the DNAH7 gene. Western blotting
and immunohistochemistry with a specific antiserum con-
firmed the lack of DNAH7 in mature PCD cilia, whereas the
DNAH7 protein was present in total cell lysates of differenti-
ated PCD cells. This observation suggested that a point muta-
tion or small insertion/deletion in DNAH7 might be responsible
for preventing its assembly into the axoneme. However, al-
though the analysis of the entire coding sequence of DNAH7 in
the PCD patient revealed several variations from the original
sequence, further screening of control subjects identified non-
PCD individuals who were homozygous for each of the variant
sequences, indicating that these differences most probably rep-
resent polymorphisms.
Our finding that DNAH7 is synthesized but not incorporated
into the cilia of the PCD cells indicates that the causative
mutation must be located in another gene. Similarly, a putative
outer arm DHC, DNAH9, was excluded as the gene responsible
for PCD in a population of patients by Bartoloni et al. (26). In
FIG. 9. Immunohistochemistry of DNAH7 in PCD cells. Paraffin
sections of well differentiated PCD cells were stained with either the
anti-DNAH7 antibody (A) or the mouse anti--tubulin IV (B). The
anti-DNAH7 antibody stained the apical cytoplasm of the ciliated cells
but did not stain the cilia, whereas the control anti--tubulin IV anti-
body reacted strongly with the cilia. Scale bar  10 m.
TABLE II
Sequence variations in DNAH7 identified in the PCD patient
Position Normal PCD
1409 AGT Ser AGT Ser
AAT Asn
1729 CGT Arg CGT Arg
TGT Cys
1991 TGC Cys TCC Ser
TCC Ser
3582 GCA Ala GCA Ala
GCC Ala
5656 GTC Val ATC Ile
ATC Ile
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a very recent report, mutations in DNAH5 have been identified
in six PCD patients by sequencing the entire coding region
from a large group of affected individuals (28). Therefore, it is
possible that the sequencing of DNAH7 from a large number of
PCD patients with inner arm defects will identify mutations in
DNAH7 as well. Other inner arm DHC genes, including DHC3
as well as genes coding for light and intermediate chain pro-
teins, would be probable candidates in these patients. Muta-
tions in an outer dynein arm intermediate chain, IC78, have
recently been identified in a small number of PCD patients
with outer arm defects (18, 29, 30). An analysis of the IC78
gene in the patient studied in this report did not identify any
mutations (30), supporting the conclusion that IC78 mutations
result in a loss of the outer dynein arms. A comparison of
isolated cilia from cultures of normal and PCD cells by two-
dimensional gel electrophoresis may identify additional inner
arm proteins that are absent in the PCD cilia. These proteins
would also be likely candidates for the site of a causative
mutation.
Alternatively, the genetic defect responsible for PCD in this
patient may be in a protein involved in the transport or assem-
bly of DNAH7 into the dynein arms. Mutations in proteins that
play a role in the assembly of axonemes have been described in
several animal models. For example, the targeted deletion of
kinesin-II subunits in mouse models results in animals that
lack nodal cilia (31, 32). The absence of functional nodal cilia in
this and other models has been associated with a randomiza-
tion of left-right asymmetry. A randomization of left-right
asymmetry is also a common feature of PCD with 50% of
patients demonstrating complete situs inversus (11, 33). The
recent results demonstrating the importance of nodal cilia in
left-right determination provide a mechanism whereby a single
mutation in an axonemal protein could cause situs inversus,
infertility, and the chronic respiratory infections observed in
PCD. In another animal model, mutations in the Tg737 gene,
which is the homologue of a Chlamydomonas gene involved in
intraflagellar transport, results in situs abnormalities, short-
ened primary cilia, and polycystic kidney disease (34, 35). Ad-
ditional studies will be required to identify the genetic defect
responsible for the lack of DNAH7 assembly and the resultant
disease in this PCD patient.
In summary, by comparing cilia from normal and PCD cells
using gel electrophoresis and mass spectrometry, we have iden-
tified an axonemal inner arm DHC. The entire coding sequence
of DNAH7 was obtained, and the expression of DNAH7 was
examined during ciliogenesis. Specific antibodies were used to
demonstrate that DNAH7 was synthesized and assembled into
the cilia of normal airway epithelial cells. In contrast, DNAH7
was synthesized but was not assembled into the cilia of a PCD
patient. No mutations were present in the coding region of
DNAH7 from the patient, although seven sequence variants
(polymorphisms) were identified. The identification of these
polymorphisms will be useful for linkage analysis studies to
investigate the role of DNAH7 in other PCD patients with a
deficiency of inner dynein arms. These studies suggest that a
mutation in another inner arm component or in a protein
involved in the assembly or transport of DNAH7 may be re-
sponsible for a subset of PCD.
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